27th Session
Omaha, Nebraska, United States of America, 21 – 25 October 2024
European Union comments on:
- Agenda item 8: Criteria and procedures for the establishment of action levels for veterinary drugs in food of animal origin resulting from unavoidable and unintentional veterinary drug carry-over in non-target animal feed
- Agenda item 9: Coordination of work between CCPR and CCRVDF
- CL 2024/65-RVDF: Maximum Residue Limits for Veterinary Drugs in Foods
26th Session
Portland, Oregon, United States of America - 13-17 February 2023
European Union comments on:
- Agenda item 6 (CL 2022/71-RVDF): MRLs for veterinary drugs in foods.
- Agenda Item 7 (CL 2022/76-RVDF): Extrapolation of MRLs for veterinary drugs in foods).
- Agenda Item 8 (CL 2022/77-RVDF): Criteria and procedures for the establishment of action levels for unintended and unavoidable carryover of veterinary drugs.
- Agenda item 9.1 (CL 2022/78 -RVDF): RVDF recommendations arising from the Joint CCPR/CCRVF Electronic Working Group.
25th Session
Virtual - 12-16 and 20 July 2021
European Union comments on:
- CL 2021/02-RVDF on the recommendations for the further steps on the use and maintenance of the database on countries’ needs for maximum residue limits for veterinary drugs in foods.
- CL 2021/05-RVDF on the principles and procedure for the parallel review of a new veterinary drug by JECFA and national regulatory agencies.
European Union reply to:
- CL 2020/42-RVDF:
- The approach for the extrapolation of maximum residue limits for veterinary drugs to one or more species.
- The proposals for MRLs based on the approach proposed for extrapolation of MRLs to one or more species.
- CL 2020/17-RVDF: "Maximum residue limits for veterinary drugs".
24th Session
Chicago, United States of America, 23-27 April 2018
European Union comments on:
- Agenda Item 6.2: Proposed draft MRLs for amoxicillin (finfish fillet, muscle); ampicillin (finfish fillet, muscle); flumethrin (honey), lufenuron (salmon and trout fillet), monepantel (cattle fat, kidney, liver, muscle) (CX/RVDF 18/24/6).
- Agenda Item 10: Discussion paper on the evaluation of the rationale for the decline in new compounds to be included in the ccrvdf priority list for evaluation by JECFA (CX/RVDF 18/24/10).
- CL 2016/41-RVDF: Priority List of Veterinary Drugs for Evaluation or Re-evaluation by JECFA
- CL 2017/72-RVDF: Draft Risk Management Recommendation (RMR) for gentian violet
- CL 2016/38-RVDF: Proposed draft MRLs for lasalocid sodium, ivermectin and teflubenzuron at step 5/8
- CL 2016/39-RVDF: Proposed Draft RMR for Gentian Violet at Step 5
23rd Session
Houston, Texas, United States of America, 17–21 October 2016
European Union comments on:
- Agenda item 5: Proposed Draft RMR for gentian violet at Step 3 (CL 2015/14-RVDF, Part B).
- Agenda item 6: Proposed draft MRLs for ivermectin, teflubenzuron and lasalocid sodium.
22nd Session
San José, Costa Rica, 27 April – 1 May 2015
European Union comments on:
- Agenda item 3: Matters Referred by the Codex Alimentarius Commission and other Committees - Codex Strategic Plan 2014-2019 (CX/RVDF 15/22/3).
- Agenda item 6c: Proposed draft MRLs for derquantel, emamectin benzoate, ivermectin, lasalocid sodium and monepantel (CX/RVDF 15/22/6) and 'concern form' from for Lasalocid sodium.
- Agenda item 6d: Proposed draft RMRs for dimitridazole, ipronidazole, metronidazole and ronidazole.
European Union reply to:
- CL 2013/26-RVDF – Part B: Draft Provisions on Establishment of MRLs for Honey